Showing results (301-310 of 1,532) with videos related to
Sort By:
Pageof 154
Current Pharmaceutical Design|March 22, 2005
Molecular mechanisms of cytokine-induced neuroprotection: NFkappaB and neuroplasticitySteven W Barger, Andréa M Moerman, Xianrong MaoTrends in Cell Biology|December 15, 2019
Squeezing in a Meal: Myosin Functions in PhagocytosisSarah R Barger, Nils C Gauthier, Mira KrendelPhysical Review Letters|February 1, 2008
Top-quark pairs at high invariant mass: a model-independent discriminator of new physics at the Large Hadron ColliderVernon Barger, Tao Han, Devin G E WalkerBMC Public Health|March 25, 2014
Social relationship correlates of major depressive disorder and depressive symptoms in Switzerland: nationally representative cross sectional studySteven D Barger, Nadine Messerli-Bürgy, Jürgen BarthCurrent Alzheimer Research|July 14, 2007
Induction of serine racemase expression and D-serine release from microglia by secreted amyloid precursor protein (sAPP)Shengzhou Wu, Anthony S Basile, Steven W BargerCurrent Treatment Options in Neurology|June 27, 2008
Low-grade gliomas in adultsSandeep Mittal, Mark C Szlaczky, Geoffrey R BargerJournal of Virology|September 21, 2007
A chaperone-activated nonenveloped virus perforates the physiologically relevant endoplasmic reticulum membraneEmily K Rainey-Barger, Brian Magnuson, Billy TsaiJournal of Virology|November 21, 2008
The C-terminal domain of ERp29 mediates polyomavirus binding, unfolding, and infectionEmily K Rainey-Barger, Souren Mkrtchian, Billy TsaiCommunity Mental Health Journal|November 2, 2013
College mental health programs: A paradigm for Comprehensive Community Mental Health centersE A Larson, B Barger, S N CahoonClinical and Experimental Hypertension (New York, N.Y. : 1993)|January 29, 2016
Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label studyAlison Handley, Eric Lloyd, Andrew Roberts, et al.Pageof 154